Harm reduction is a public health approach that focuses on minimizing the negative consequences of risky behaviors, rather than demanding that people stop those behaviors entirely. It’s most commonly associated with drug use, but the concept applies broadly: condoms for safer sex, nicotine patches for smokers, and seatbelts for drivers all follow the same logic. The core idea is that people who aren’t ready or able to stop a behavior can still take steps to protect their health.
The Principles Behind Harm Reduction
Harm reduction rests on a set of principles that distinguish it from traditional abstinence-only models. Research published in the Harm Reduction Journal identified six: humanism, pragmatism, individualism, autonomy, incrementalism, and accountability without termination. In practice, these translate into a straightforward philosophy.
Humanism means treating every person with dignity, regardless of what they’re using or how they’re living. Pragmatism means accepting that people will engage in risky behavior whether or not a provider approves, so the practical goal is to make that behavior less dangerous. Individualism recognizes that no single protocol works for everyone. Autonomy means the person, not the provider, ultimately makes decisions about their own health. Incrementalism treats any positive change, no matter how small, as meaningful progress, even if that progress takes years. And accountability without termination means people are never “fired” from care for failing to meet goals.
One healthcare worker captured the pragmatic philosophy bluntly: a patient using heroin still needed to take her medications, because the disease would kill her faster than the drug would. The provider didn’t condone the drug use. But pretending it wasn’t happening, or refusing care because of it, would only have made the outcome worse.
How It Works in Practice
Harm reduction takes many forms depending on the behavior and the risk involved. For people who inject drugs, the most established programs include syringe services, overdose prevention through naloxone distribution, supervised consumption sites, and drug checking services. For tobacco users, nicotine replacement therapies like patches and gums follow the same principle: reduce the damage without requiring immediate abstinence. Safe sex education and condom distribution are harm reduction strategies that most people already take for granted.
The approach also extends into less obvious areas. Therapists working within a harm reduction framework might encourage someone struggling with binge eating to try healthier alternatives, support someone who self-harms by providing clean supplies to reduce infection risk, or celebrate a sedentary patient for committing to just five minutes of exercise a day. The thread connecting all of these is the same: meet people where they are and help them move toward better health on their own terms.
Syringe Service Programs
Syringe service programs, sometimes called needle exchanges, provide sterile injection equipment to people who inject drugs. Their primary goal is preventing the spread of bloodborne infections like HIV and hepatitis C, which transmit easily through shared needles. According to HIV.gov, these programs are associated with an approximately 50% reduction in both HIV and hepatitis C incidence among people who use them.
Beyond the needles themselves, these programs serve as a bridge to other health services. Many participants access HIV and hepatitis C testing and treatment through syringe service sites, and many are connected to medication-assisted treatment for opioid use disorder. In Malaysia, a national syringe program prevented an estimated 12,191 HIV infections between 2006 and 2013, saving $9.6 million in treatment costs.
Naloxone and Overdose Prevention
Naloxone is a medication that reverses opioid overdoses, and distributing it to people who use drugs, their families, and first responders is one of the most effective harm reduction strategies available. A systematic review and meta-analysis published in BMC Public Health found that 97.3% of people who received naloxone during an overdose survived. Among programs that distributed naloxone directly to people who use drugs, the survival rate was even higher: 98.3%.
The effects show up at the community level too. In Massachusetts, communities that trained more than 100 people per 100,000 residents to use naloxone saw a 46% reduction in opioid overdose deaths compared to communities with no such program. Communities with lower levels of training still saw a 27% reduction. In Chicago, annual overdose deaths had been rising 2.4-fold in the four years before a naloxone distribution program launched; in the three years after, deaths dropped by 30%. Scotland’s national naloxone program, which targeted people recently released from prison (a period of extremely high overdose risk), reduced opioid-related deaths in that group by 36%.
Supervised Consumption Sites
Supervised consumption sites are facilities where people can use pre-obtained drugs under medical supervision. While overdoses still occur at these sites (roughly 1 per 1,000 injections), no fatal overdoses have been reported at any supervised consumption site worldwide. Staff intervene immediately with oxygen, naloxone, and other support.
The benefits extend into the surrounding neighborhood. Near one site, monthly ambulance calls requiring naloxone for suspected opioid overdoses dropped from 27 to 9, a 67% reduction. Modeling studies estimate that supervised consumption sites are associated with 88 fewer overdose deaths per 100,000 person-years. A study in Seattle estimated that establishing such a facility would save $4.22 in healthcare costs for every dollar spent on operations.
Drug Checking Services
Fentanyl test strips allow people to check their drugs for the presence of fentanyl, which is now involved in the majority of overdose deaths in the United States. The question with any harm reduction tool is whether people actually change their behavior based on the information, and the evidence suggests they do. A study at a syringe services program in the Southeastern U.S. found that 43% of participants reported changing their drug use behavior after using test strips, and 77% said they felt safer from overdose. People who received a positive result (meaning fentanyl was detected) had five times the odds of changing their behavior compared to those with a negative result.
Those behavioral changes can include using smaller amounts, not using alone, keeping naloxone nearby, or deciding not to use that particular batch at all. None of these responses require abstinence, but each one reduces the chance of a fatal outcome.
The Policy Landscape
Harm reduction has been endorsed by major health organizations around the world, including the World Health Organization and, until recently, by U.S. federal agencies. However, the political landscape has shifted. As of July 2025, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance deprioritizing harm reduction and “safe consumption” efforts from its grant funding, describing them as programs that “only facilitate illegal drug use and its attendant harm.” SAMHSA stated it will not support the use or distribution of illegal drugs and associated paraphernalia.
This represents a significant reversal from previous federal policy, which had directed funding toward harm reduction as part of the national response to the opioid crisis. Many state and local programs continue to operate with non-federal funding, and the evidence base supporting these programs has not changed. But the shift means that access to certain services may vary significantly depending on where you live and how your local programs are funded.